Results 151 to 160 of about 34,612 (242)

Switching Patients With Congenital Adrenal Hyperplasia to Modified‐Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Background Replacement therapy with modified‐release hydrocortisone capsules (MRHC) restores the physiological circadian cortisol rhythm in congenital adrenal hyperplasia (CAH). Aims To determine the relative bioavailability of MRHC and evaluate an optimal protocol to switch CAH patients from standard therapy to MRHC.
Richard John M. Ross   +15 more
wiley   +1 more source

Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton   +4 more
wiley   +1 more source

Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2647-2657, May 2025.
Abstract Objective Roux‐en‐Y gastric bypass (RYGB) surgery has been shown to lead to favourable health outcomes in obese patients. However, the molecular changes that occur and how they relate to clinical measures are poorly understood. Here, we characterise the proteomic alterations that occur in plasma of RYGB patients before and 9 months after ...
Hasnain Ahmed   +6 more
wiley   +1 more source

Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
The findings demonstrated no significant difference in MACE between the sirolimus‐treated and untreated groups (hazard ratio, 1.40; 95% confidence interval, .77–2.55), despite a higher incidence of dyslipidaemia in the sirolimus‐treated group. However, subgroup analysis indicated an increased MACE risk in KTRs with pre‐transplant congestive heart ...
Jinhyun Park   +8 more
wiley   +1 more source

Key biomarkers in type 2 diabetes patients: A systematic review. [PDF]

open access: yesDiabetes Obes Metab
Le TN   +5 more
europepmc   +1 more source

The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Immature granulocyte (IG) count and percentage had a predictive role in patients with decompensated cirrhosis, making them an objective and easily available marker of prognosis for this group of patients. In addition, IG percentage was the only factor independently associated with transplant‐free survival.
Magdalini Adamantou   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy